Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Astellas Pharma Inc (JP:4503)
TSE/TYO:4503
Holding JP:4503?
Track your performance easily
4503 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥1,426.00 - ¥1,839.50
Previous Close¥1,572.5
Volume4.94M
Average Volume (3M)5.83M
Market Cap
¥2.81T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)51.0
Beta0.47
Next Earnings
Jan 30, 2025EPS Estimate
¥18.49Next Dividend Ex-Date
Mar 28, 2025Dividend Yield4.75%
Share Statistics
EPS (TTM)30.60
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume5,830,483
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,954.82Price Target Upside24.31% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Astellas Pharma News
PremiumCompany Announcements
Astellas Faces FDA Setback on IZERVAY Application
PremiumCompany Announcements
Astellas Pharma Faces Currency Losses in FY2024
PremiumCompany Announcements
Astellas Pharma Withdraws EU Application for Key Drug
PremiumCompany Announcements
Astellas Pharma’s VYLOY Gains FDA Approval for Cancer TreatmentPremiumCompany Announcements
Astellas’ New Cancer Therapy Gains Japan ApprovalPremiumCompany Announcements
Astellas Wins EU Approval for Advanced Cancer Drug
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
7.48% Mutual Funds
― Other Institutional Investors
83.34% Public Companies and
Individual Investors
4503 FAQ
What was Astellas Pharma Inc’s price range in the past 12 months?
Astellas Pharma Inc lowest stock price was ¥1426.00 and its highest was ¥1839.50 in the past 12 months.
What is Astellas Pharma Inc’s market cap?
Currently, no data Available
When is Astellas Pharma Inc’s upcoming earnings report date?
Astellas Pharma Inc’s upcoming earnings report date is Jan 30, 2025 which is in 70 days.
How were Astellas Pharma Inc’s earnings last quarter?
Astellas Pharma Inc released its earnings results on Oct 30, 2024. The company reported ¥20.06 earnings per share for the quarter, beating the consensus estimate of ¥18.013 by ¥2.047.
Is Astellas Pharma Inc overvalued?
According to Wall Street analysts Astellas Pharma Inc’s price is currently Undervalued.
Does Astellas Pharma Inc pay dividends?
Astellas Pharma Inc pays a Annually dividend of ¥37 which represents an annual dividend yield of 4.75%. See more information on Astellas Pharma Inc dividends here
What is Astellas Pharma Inc’s EPS estimate?
Astellas Pharma Inc’s EPS estimate is ¥18.49.
How many shares outstanding does Astellas Pharma Inc have?
Astellas Pharma Inc has 1,809,663,100 shares outstanding.
What happened to Astellas Pharma Inc’s price movement after its last earnings report?
Astellas Pharma Inc reported an EPS of ¥20.06 in its last earnings report, beating expectations of ¥18.013. Following the earnings report the stock price went down -0.084%.
Which hedge fund is a major shareholder of Astellas Pharma Inc?
Currently, no hedge funds are holding shares in JP:4503
---
Astellas Pharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-21.29%
12-Months-Change
Fundamentals
Return on Equity
3.28%
Trailing 12-Months
Asset Growth
1.95%
Trailing 12-Months
Company Description
Astellas Pharma Inc
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
---
4503 Company Deck
---
4503 Earnings Call
Q2 2024
0:00 / 0:00
---
4503 Stock 12 Month Forecast
Average Price Target
¥1,954.82
▲(24.31% Upside)
Technical Analysis
Best Analysts Covering 4503
1 Year
---